article · Zenodo (CERN European Organization for Nuclear Research)
This record contains supporting documents for the study protocol, “Extended dosing intervals for Euvichol-S oral cholera vaccine in participants aged one year and older in Nairobi, Kenya: protocol for a phase IV randomized non-inferiority trial.” The trial is being conducted in Mukuru, Nairobi, Kenya, and compares second-dose Euvichol-S intervals of two weeks, three months, and twelve months among participants aged one year and older. The trial is registered with the Pan African Clinical Trials Registry (PACTR202501835187008). The deposited files comprise the approved study protocol, version 1.2 dated 31 July 2025, the completed SPIRIT 2025 checklist, and the completed TIDieR checklist.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.5281/zenodo.21877239
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
